Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KET-AIR Trial: Nebulized Ketamine in Moderate to Severe Asthma Exacerbations
NCT07112456Phase 2Recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- May 2026
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in asthma, sponsored by Oman Medical Specialty Board. Started May 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07112456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112456.